| |
| |
|
| Insider
Information: |
Ray Nitya G. |
| Relationship: |
Chief Technology Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
520,090 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$291,318 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
520,090 |
|
|
| Total
Value |
$291,318 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Actinium Pharmaceuticals Inc |
ATNM |
Executive VP |
2018-03-06 |
20,000 |
2017-08-02 |
0 |
Premium* |
|
|
Cytodyn Inc |
CYDY |
Chief Technology Officer |
2022-11-15 |
500,090 |
2020-09-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,671 |
500,090 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
16,084 |
486,419 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,428 |
470,335 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
13,020 |
457,907 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,965 |
444,887 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
10,516 |
435,922 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,588 |
425,406 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,102 |
418,818 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,428 |
411,716 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
13,020 |
399,288 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,671 |
386,268 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17,089 |
372,597 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,084 |
355,508 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
17,089 |
339,424 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,254 |
322,335 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,780 |
302,081 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
87,301 |
287,301 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Chief Technology Officer |
• – – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
200,000 |
0 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Executive VP |
• – – |
2018-03-06 |
4 |
A |
$0.50 |
$5,000 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Executive Vice President |
• – – |
2017-08-02 |
4 |
B |
$0.75 |
$7,500 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
